Charles River Laboratories

Charles River Laboratories offers critical research and development services, enabling pharmaceutical, biotechnology, and academic organizations to bring new therapies to market. The company specializes in preclinical and clinical laboratory support, providing expertise in drug discovery, safety assessment, and process manufacturing. Their comprehensive portfolio helps clients navigate complex development pathways for novel drugs, vaccines, and medical devices, streamlining the journey from early-stage research through commercialization.

The company was founded in 1947 by a young veterinarian who established a one-man laboratory in Boston, near the Charles River. His initial insight focused on addressing the need for high-quality, standardized animal models crucial for scientific research. This foundational emphasis on reliable biological models and controlled research environments laid the groundwork for Charles River Laboratories' subsequent expansion into a broad array of drug development services.

Charles River Laboratories serves a diverse global client base of pharmaceutical and biotechnology firms, contributing to the advancement of medical science. Their vision centers on being an indispensable partner in the drug development pipeline, dedicated to accelerating the discovery, development, and safe manufacturing of new treatments. The company aims to facilitate the delivery of life-saving and life-improving therapies to patients worldwide.